Logo - springer
Slogan - springer

Biomedical Sciences - Pharmacology & Toxicology | Drugs & Therapy Perspectives – incl. option to publish open access

Drugs & Therapy Perspectives

Drugs & Therapy Perspectives

Editor: Katherine Lyseng-Williamson

ISSN: 1172-0360 (print version)
ISSN: 1179-1977 (electronic version)

Journal no. 40267

Springer Open Access

Concise, authoritative aid to drug decision-making and an essential publication for pharmacists and physicians who need to make formulary and prescribing decisions. A digest of the latest peer-reviewed drug knowledge presented in an easy to read form, including:

Information on formulary comparisons using differential features tables

Step-by-step clinical decision-making using patient care guidelines

Overviews of drugs and their place in therapy

Questions and answers on the clinical use of drugs

Current thinking on disease management

Clinically useful pharmacodynamics and pharmacoeconomics

Hot topics in adverse drug reactions and drug interactions

International viewpoints on topics of significant clinical importance

Related subjects » Adis

Abstracted/Indexed in 

SCOPUS, EMBASE, Google Scholar, EBSCO, Academic OneFile, Academic Search, CINAHL, CSA Environmental Sciences, Health Reference Center Academic, Journals@OVID, OCLC, SCImago, Summon by ProQuest

Popular Content within this publication 

 

Articles

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Drugs & Therapy Perspectives provides concise, authoritative review articles to aid drug formulary and prescribing decisions. It is a digest of the latest drug knowledge covering the most important aspects of clinical therapeutics, including:

    • Questions and answers on the clinical use of drugs.
    • Comparisons of the features of various drugs, using differential feature tables.
    • Current thinking on disease management.
    • Step-by-step clinical decision-making, illustrated with patient care algorithms.
    • First reports of serious adverse drug reactions.
    • Clinically useful pharmacodynamics and pharmacokinetics.
    • Developments in pharmacoeconomics and other research that have a bearing on clinical practice
    • Original Research Articles focusing on the use of drugs in clinical practice.
    All material is prepared by Adis editors and medical writers, unless otherwise noted. The preparation of material is not supported by any external funding. All review articles are subject to peer review by members of the journal's international editorial board and/or other experts.
  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors

    Close

  • Author declaration form (pdf, 125 kB)
  • Copyright information

    Copyright information

    Close

    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.


    © Springer International Publishing Switzerland

Services for the Journal

Alerts for this journal

 

Get the table of contents of every new issue published in Drugs & Therapy Perspectives.


Additional information